Future investigations will interrogate the molecular nature of YAP1 and HES1 convergence on CDKN1C, the transcriptional program governed by HES1 in FN‐RMS tumorigenesis, and the impact on FN‐RMS cell fate decisions, informing potential therapeutic opportunities for this childhood cancer. Here, HES1 is linked to childhood malignant neoplasm.